BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Albayrak A, Ertek M, Tasyaran MA, Pirim I. Role of HLA allele polymorphism in chronic hepatitis B virus infection and HBV vaccine sensitivity in patients from eastern Turkey. Biochem Genet. 2011;49:258-269. [PMID: 21188498 DOI: 10.1007/s10528-010-9404-6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
Number Citing Articles
1 Yan ZH, Fan Y, Wang XH, Mao Q, Deng GH, Wang YM. Relationship between HLA-DR gene polymorphisms and outcomes of hepatitis B viral infections: A meta-analysis. World J Gastroenterol 2012; 18(24): 3119-3128 [PMID: 22791948 DOI: 10.3748/wjg.v18.i24.3119] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 28] [Article Influence: 2.4] [Reference Citation Analysis]
2 Moudi B, Heidari Z, Mahmoudzadeh-sagheb H. Impact of host gene polymorphisms on susceptibility to chronic hepatitis B virus infection. Infection, Genetics and Evolution 2016;44:94-105. [DOI: 10.1016/j.meegid.2016.06.043] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 3.7] [Reference Citation Analysis]
3 Lorente L, Martín MM, Franco A, Barrios Y, Cáceres JJ, Solé-Violán J, Perez A, Marcos Y Ramos JA, Ramos-Gómez L, Ojeda N, Jiménez A; Working Group on COVID-19 Canary ICU., Annex. Members of the BIOMEPOC group. [HLA genetic polymorphisms and prognosis of patients with COVID-19]. Med Intensiva (Engl Ed) 2021;45:96-103. [PMID: 32988645 DOI: 10.1016/j.medin.2020.08.004] [Cited by in Crossref: 18] [Cited by in F6Publishing: 24] [Article Influence: 9.0] [Reference Citation Analysis]
4 Lương KVQ, Nguyễn LTH. Theoretical basis of a beneficial role for vitamin D in viral hepatitis. World J Gastroenterol 2012; 18(38): 5338-5350 [PMID: 23082050 DOI: 10.3748/wjg.v18.i38.5338] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
5 Wang T, Qi J, Li H, Chen L, Liu S, Shen C. Human leukocyte antigen class I association with occult hepatitis B virus infection in the Shaanxi Han group: Analysis at the haplotype level. J Gene Med 2022;24:e3393. [PMID: 34643983 DOI: 10.1002/jgm.3393] [Reference Citation Analysis]
6 Choga WT, Anderson M, Zumbika E, Phinius BB, Mbangiwa T, Bhebhe LN, Baruti K, Kimathi PO, Seatla KK, Musonda RM, Bell TG, Moyo S, Blackard JT, Gaseitsiwe S. In Silico Prediction of Human Leukocytes Antigen (HLA) Class II Binding Hepatitis B Virus (HBV) Peptides in Botswana. Viruses 2020;12:E731. [PMID: 32640609 DOI: 10.3390/v12070731] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Seshasubramanian V, Soundararajan G, Ramasamy P. Human leukocyte antigen A, B and Hepatitis B infection outcome: A meta-analysis. Infect Genet Evol 2018;66:392-8. [PMID: 28757339 DOI: 10.1016/j.meegid.2017.07.027] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
8 Ito K, Yoneda M, Sakamoto K, Mizokami M. Virological and Clinical Characteristics of Hepatitis B Virus Genotype A. J Gastroenterol 2018;53:18-26. [PMID: 28687901 DOI: 10.1007/s00535-017-1367-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
9 Ramezani A, Banifazl M, Mamishi S, Sofian M, Eslamifar A, Aghakhani A. The influence of human leukocyte antigen and IL-10 gene polymorphisms on hepatitis B virus outcome. Hepat Mon. 2012;12:320-325. [PMID: 22783343 DOI: 10.5812/hepatmon.6094] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
10 Zhang GL, Keskin DB, Lin HN, Lin HH, DeLuca DS, Leppanen S, Milford EL, Reinherz EL, Brusic V. Human leukocyte antigen typing using a knowledge base coupled with a high-throughput oligonucleotide probe array analysis. Front Immunol 2014;5:597. [PMID: 25505899 DOI: 10.3389/fimmu.2014.00597] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
11 DiGiacomo D, Santonicola A, Zingone F, Troncone E, Caria MC, Borgheresi P, Parrilli G, Ciacci C. Human leukocyte antigen DQ2/8 prevalence in non-celiac patients with gastrointestinal diseases. World J Gastroenterol 2013; 19(16): 2507-2513 [PMID: 23674852 DOI: 10.3748/wjg.v19.i16.2507] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
12 Tajiri K, Shimizu Y. Unsolved problems and future perspectives of hepatitis B virus vaccination. World J Gastroenterol 2015; 21(23): 7074-7083 [PMID: 26109794 DOI: 10.3748/wjg.v21.i23.7074] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
13 Hung SC, Hou T, Jiang W, Wang N, Qiao SW, Chow IT, Liu X, van der Burg SH, Koelle DM, Kwok WW, Sollid LM, Mellins ED. Epitope Selection for HLA-DQ2 Presentation: Implications for Celiac Disease and Viral Defense. J Immunol 2019;202:2558-69. [PMID: 30926644 DOI: 10.4049/jimmunol.1801454] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
14 Miao F, Sun H, Pan N, Xu J, Qiu J, Shen Y, Xie W, Zhang J. Association of human leukocyte antigen class I polymorphism with spontaneous clearance of hepatitis B surface antigen in Qidong Han population. Clin Dev Immunol 2013;2013:145725. [PMID: 24324503 DOI: 10.1155/2013/145725] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
15 Song QL, He XX, Yang H, Li J, Chen M, Wang MY, Liu Q, Yu JL, Yao JJ, Liu LF, Sun SZ, Lin JS. Association of a TANK gene polymorphism with outcomes of hepatitis B virus infection in a Chinese Han population. Viral Immunol 2012;25:73-8. [PMID: 22225470 DOI: 10.1089/vim.2011.0053] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
16 Zeng Z. Human genes involved in hepatitis B virus infection. World J Gastroenterol 2014; 20(24): 7696-7706 [PMID: 24976707 DOI: 10.3748/wjg.v20.i24.7696] [Cited by in CrossRef: 35] [Cited by in F6Publishing: 27] [Article Influence: 4.4] [Reference Citation Analysis]
17 Lorente L, Jiménez A. Validation of medical researchs. Med Intensiva (Engl Ed) 2021:S0210-5691(21)00030-9. [PMID: 33810872 DOI: 10.1016/j.medin.2021.02.010] [Reference Citation Analysis]